BrainCo's brain-computer interface (BCI) garnered significant attention at the HSBC summit with a demonstration of a bionic hand controlled by thought. This was reported by SCMP.
The technology allows for non-invasive reading of neural signals through the skin, converting them into commands for devices. This capability also aids patients in managing symptoms of certain conditions.
“For serious brain diseases like Parkinson's or for blind individuals, surgical intervention may be necessary. However, there are alternative approaches, such as ours,” said Nix He, partner and senior vice president of BrainCo.
During the event, the company conducted a live demonstration. A man with a bionic hand showcased the device's response to nerve impulses, moving his fingers solely through thought.
Company representatives stated that this is the world's first prosthetic that allows independent control of each finger.
The participant then played a short piece on the piano.
“The sensors merely touch the skin and read the neural signals beneath it. Then, the muscles contract to move the hand,” He explained.
According to her, the non-invasive approach is safer, more readily accepted by patients, and reduces risks and costs.
A well-known player in the BCI field, Neuralink, employs an invasive method. The company inserts ultra-thin threads with electrodes into brain tissue to read neuron activity related to intentions. This method offers higher precision, but the signal quality diminishes over time.
He noted that her company's technology could also be used to enhance focus and improve sleep quality.
BrainCo was founded in the U.S. by Harvard graduate Han Bicheng. He holds a law degree from Harvard Law School.
Last year, the firm established its Asia-Pacific headquarters and a research base in Hong Kong's Cyberport.
Notably, in March, China's regulator approved the country's first neuroimplant for commercial use.